Search

everythinglearnresearchcommunity

for

Search:↓

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Aromatase inhibitors cause male pattern hair loss in women.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

iL-PRF treatment improves hair growth for androgenetic alopecia.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

PDCD4 is important for controlling skin cell growth and healing.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Women with alopecia may have a higher chance of getting thyroid cancer.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Hair stiffness is higher when it has more para-like cortical cells.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The document concludes that hair follicles have a complex environment and our understanding of it is growing, but there are limitations when applying animal study findings to humans.

ESR2 gene linked to female-pattern hair loss.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Trichobiolight effectively treats hair loss with 82.5% success.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Certain Prakruti types are more prone to early male pattern baldness.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Acupressure improves quality of life in PCOS patients.